Difference between revisions of "Eluvixtamab (AMG-330)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) |
||
| Line 3: | Line 3: | ||
==Also known as== | ==Also known as== | ||
| − | *'''Code name:''' AMG 330 | + | *'''Code name:''' AMG-330 |
[[Category:Drugs]] | [[Category:Drugs]] | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
| − | |||
[[Category:T-cell activators]] | [[Category:T-cell activators]] | ||
Revision as of 22:05, 25 July 2023
Mechanism of action
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3
Also known as
- Code name: AMG-330